1.
Achieving Depth of Response in Skin Clearance and Itch Relief With Lebrikizumab is Associated With Minimal Impact of Atopic Dermatitis on Quality of Life. J of Skin. 2025;9(1):s516. doi:10.25251/skin.9.supp.516